language-icon Old Web
English
Sign In
Acemap > Paper > ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.

2010 
ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    17
    References
    15
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.